v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | EUCTR2021-000930-32-BE |
Full text link
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-000930-32/BE |
First author
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
|
Contact
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
ctc@azsintjan.be |
Registration date
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
2021-03-04 |
Recruitment status
Last imported at : Oct. 15, 2022, 12:30 a.m. Source : EU Clinical Trials Register |
Completed |
Study design
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
nonRCT |
Allocation
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Non-randomized |
Design
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Single group assignment |
Masking
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Open label |
Center
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
multi-center |
Study aim
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Prevention |
Inclusion criteria
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
1. Consecutive series of hemodialysis patients receiving Covid-19 RNA vaccine. A target of at least 100 patients is envisioned. Minimum age for inclusion is 18 years. 2. at least thirty healthy volunteers receiving Covid-19 RNA vaccine. Minimum age for inclusion is 18 years. Individuals with immune disorders cannot participate. 3. at least thirty patients older than 50 years with at least 1 comorbidity (such as heart failure, diabetes, COPD, liver cirrhosis,....), but no chronic renal insufficiency. Minimum age for inclusion is 18 years. Only patients who receive vaccine on a voluntary basis will be included. |
Exclusion criteria
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
- patients younger than 18 years old - patients who do not voluntarily ask for a COVID-vaccination - patients not eligible according to abovementioned inclusion criteria |
Number of arms
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
1 |
Funding
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
AZ Sint-Jan Brugge-Oostende AV |
Inclusion age min
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
18 |
Inclusion age max
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
100 |
Countries
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Belgium |
Type of patients
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
High risk patients |
Severity scale
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
N/A |
Total sample size
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
580 |
primary outcome
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
1. Measurement of anti-S and anti-N antibodies. SARS-CoV-2 IgG against the S and N protein will be quantitatively measured by chemiluminescent microparticle immunoassay (Architect-I System by Abbott, Sligo, Ireland). 2. Measurement of interferon gamma production. Interferon production by SARS-CoV specific T cells will be measured using the QuantiFERON Sars-CoV-2 kit (Qiagen). 3. Baseline immune status (only in hemodialysis patients). Before vaccination the following parameters are determined: number of lymphocytes, number of CD4 positive lymphocytes, number of CD8 positive lymphocytes, number of CD19 positive lymphocytes, B and T cell memory subsets, protein electrophoresis, C3, C4, total IgG, IgA and IgM. |
Notes
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Declared number of arm (1.0) differs from found arms (2.0) |
Phase
Last imported at : April 28, 2021, 3:52 p.m. Source : EU Clinical Trials Register |
Phase 4 |
Arms
Last imported at : Oct. 15, 2022, 12:30 a.m. Source : EU Clinical Trials Register |
[{"arm_notes": "", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}] |